Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03503396
Other study ID # 2010187
Secondary ID R01AA019546-06A1
Status Completed
Phase N/A
First received
Last updated
Start date April 2, 2018
Est. completion date January 20, 2019

Study information

Verified date April 2023
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot study to set up a larger investigation examining predictors of the decision to drive after consuming alcohol. All participants will carry a study provided smartphone and breathalyzer device for the 2 week period of the study. The intervention is that participants are randomly assigned to one of 2 breathalyzer feedback conditions - one where they receive a warning that their results indicate they should not drive and one where they receive no feedback. The study is designed to provide information needed for a larger version with a similar protocol, but also to provide an initial test of project hypotheses as well.


Description:

Despite previous success in reducing alcohol impaired driving (AID) and fatal crashes, rates have not decreased significantly since the 1990s. Developing novel approaches to prevention/intervention are likely required to produce further progress. This project is designed to evaluate a potential intervention for AID using mobile technology. In addition, the project is designed to provide pilot data for a large scale investigation. Recent laboratory work by the PI has demonstrated the utility of assessing AID risk factors when participants are intoxicated. We identified four risk factors that, measured under intoxication, are cross-sectional predictors of AID: AID attitudes (Morris et al., 2014), impulsivity (McCarthy et al., 2012), behavioral economic demand (Amlung et al., 2016) and subjective intoxication (Amlung et al., 2014). The proposed project will evaluate these factors as prospective predictors of AID and extend this work outside the laboratory and into participants' natural drinking environment using Ambulatory Assessment (AA). AA is a set of techniques used to collect data from individuals in the course of their daily life. AA methods provide increased ecological validity across multiple modalities (e.g., self-report, physiological measures). No study to date has used AA to examine AID. We will employ a combination of three AA methods: ecological momentary assessment, geospatial technology, and portable breath analysis. Ecological Momentary Assessment (EMA) is a form of AA that allows participants to self-report on their current thoughts, feelings, and behaviors in their natural environment (Shiffman et al., 2008). EMA avoids most pitfalls of retrospective reports, and is increasingly used to study temporally proximal influences on substance use behaviors (Shiffman, 2009). Despite the importance of such influences to AID decisions (Quinn & Fromme, 2012), no study to date has applied EMA methods to the study of AID. Advancements in mobile technology, such as global position systems (GPS) and portable breathalizers, allow for the collection of objective data on participant location and alcohol use in real-time. We will combine location data (e.g., drinking venue, distance from home) and in-the-moment breathalyzer data with self-report EMA data from each participant drinking episode. This combination will allow for a more complete assessment of event-level factors that contribute to AID decisions. This pilot project will test the hypothesis that temporally proximal measures of AID risk factors (subjective impairment, perceived risk) collected during a drinking episode will improve prediction of AID, over and above trait measures of AID risk factors. The pilot project will also test the potential for AA to function as an intervention for AID. In this pilot, participants will be randomly assigned to either receive some feedback from their breathalyzer (a warning that they have consumed too much to drive safely) or not to receive any feedback. Note that participants will not be told their BAC, due to potential risks of specific feedback (increased consumption, titrating drinking to drive at slightly below .08). Instead, feedback will be general ("Your results indicate that you have drank too much to drive safely"), and participants will not be aware of what BAC triggers these warnings. Comparisons of all participants AID behavior at baseline (from a Timeline Follow-back assessment) with their AID behavior during study participation will be used to test whether the increased self-monitoring of AA can alter AID decisions. In addition, comparisons between groups (feedback vs. none) will test for potential effects of BAC feedback on AID decisions. Support for these hypotheses could lead to novel, cost-effective interventions to reduce AID using mobile technology. This pilot will enroll 40 moderate-to-heavy drinking young adults. Participants will complete a brief laboratory session of AID risk measures, followed by two weeks of AA. They will be randomly assigned to one of two conditions (BAC feedback vs. none). Interview assessments of AID will be conducted at baseline and at the completion of AA assessments, with interviewers blind to condition.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date January 20, 2019
Est. primary completion date January 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 30 Years
Eligibility Inclusion Criteria: - moderate to heavy drinkers. - must drive regularly (including driving for social events). - report binge drinking (4/5 drinks in a 2 hour period) at least once in the past month - fluent in english Exclusion Criteria: - no exclusion criteria other than failure to meet inclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
BAC Driving Feedback/Warning
Participants will receive a warning at a set BAC limit, indicating they are too impaired to drive.
No Feedback
Participants will receive no information about BAC, but will still complete study assessments and provide breath samples during drinking sessions.

Locations

Country Name City State
United States University of Missouri-Columbia Columbia Missouri

Sponsors (2)

Lead Sponsor Collaborator
University of Missouri-Columbia National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Proximal Predictors of Impaired Driving Outside of the intervention effect, observational data will be used to test hypotheses about proximal predictors of driving behavior. 2 weeks of study intervention
Other Effect of Self-monitoring on AID Behavior and Perceptions Outside of the intervention effect, observational data will be used to test hypotheses about whether all participants report reduced driving after drinking and increase perceive risk of driving after drinking during the intervention period. 2 weeks of study intervention
Primary Alcohol Impaired Driving Behavior Change in number of times driven after drinking per week from pre (4 week TLFB) to post (2 week TLFB). A Timeline Followback (TLFB) is an interview where the participant self-reports their drinking behavior including: where they were drinking, how much they drank of what over what period of time, what location they went to next, how they got there. Baseline (4 week prior to initial interview) and trial period (2 weeks after initial interview)
Secondary Perceived Risk of Driving After Drinking Rating of danger of driving after receiving warning. Participants were asked to rate the perceived dangerousness of driving during drinking episodes by asking them to "indicate how dangerous you feel it would be for you to drive "right now"" Responses are recorded on a 1 (not at all dangerous) to 10 (extremely dangerous) visual analogue scale. Self-reported current perception (i.e., "right now")
See also
  Status Clinical Trial Phase
Completed NCT00648206 - Testing Alcohol Only Samples for Drugs and Drugs Only Samples for Alcohol N/A
Completed NCT04230460 - Cannabis Impairment Detection Application (CIDA) N/A
Completed NCT03506880 - Project MADD - NIH Underage DUI and Ride N/A
Completed NCT05028413 - Evaluating Perceived Fitness to Drive While Intoxicated N/A
Completed NCT02071836 - A Web Application to Reduce Heavy Drinking in First-time DWI Offenders N/A
Completed NCT00650130 - Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines N/A
Recruiting NCT04450966 - Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care N/A
Completed NCT04247191 - Parent Intervention to Reduce College Student Drinking and Consequences N/A
Completed NCT04970342 - Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim Phase 1
Completed NCT03335735 - Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving N/A
Active, not recruiting NCT01590277 - Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans Phase 1
Withdrawn NCT05273658 - Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests Phase 1/Phase 2
Completed NCT05437081 - A Family-Based Alcohol Preventive Intervention for Latino Emerging Adults N/A
Not yet recruiting NCT05526196 - Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes N/A